Luca Malorni

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 20

Top Topics

Positive Breast Cancer

Endoplasmic Reticulum

Estrogen Receptor

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Cristina Guarducci, Agostina Nardone, Douglas Russo, Zsuzsanna Nagy, Capucine Heraud, Albert Grinshpun, Qi Zhang, Allegra Freelander, Matthew Joseph Leventhal, Avery Feit, Gabriella Cohen, Ariel Feiglin, Weihan Liu, Francisco Hermida-Prado, Nikolas Kesten, Wen Ma, Carmine De Angelis, Antonio Morlando, Madison O'Donnell, Sergey Naumenko, Shixia Huang, Quang-De Nguyen, Ying Huang, Luca Malorni, Johann S Bergholz Villafane, Jean J Zhao, Ernest Fraenkel, Elgene Lim, Rachel Schiff, Geoffrey I Shapiro, Rinath M Jeselsohn
Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor-positive Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Ilenia Migliaccio, Dario Romagnoli, Francesca Galardi, Francesca De Luca, Chiara Biagioni, Curigliano Giuseppe, Carmen Criscitiello, Alessandro Marco Minisini, Erica Moretti, Emanuela Risi, Cristina Guarducci, Agostina Nardone, Laura Biganzoli, Matteo Benelli, Luca Malorni
Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial. JCO precision oncology 8 (2024)
Ilenia Migliaccio, Dario Romagnoli, Francesca Galardi, Francesca De Luca, Chiara Biagioni, Curigliano Giuseppe, Carmen Criscitiello, Alessandro Marco Minisini, Erica Moretti, Emanuela Risi, Cristina Guarducci, Agostina Nardone, Laura Biganzoli, Matteo Benelli, Luca Malorni
Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial. JCO precision oncology 8 (2024)
Cristina Guarducci, Agostina Nardone, Douglas Russo, Zsuzsanna Nagy, Capucine Heraud, Albert Grinshpun, Qi Zhang, Allegra Freelander, Matthew Joseph Leventhal, Avery Feit, Gabriella Cohen, Ariel Feiglin, Weihan Liu, Francisco Hermida-Prado, Nikolas Kesten, Wen Ma, Carmine De Angelis, Antonio Morlando, Madison O'Donnell, Sergey Naumenko, Shixia Huang, Quang-De Nguyen, Ying Huang, Luca Malorni, Johann S Bergholz Villafane, Jean J Zhao, Ernest Fraenkel, Elgene Lim, Rachel Schiff, Geoffrey I Shapiro, Rinath M Jeselsohn
Selective CDK7 inhibition suppresses cell cycle progression and MYC signaling while enhancing apoptosis in therapy-resistant estrogen receptor positive breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Cristina Guarducci, Agostina Nardone, Douglas Russo, Zsuzsanna Nagy, Capucine Heraud, Albert Grinshpun, Qi Zhang, Allegra Freelander, Matthew Joseph Leventhal, Avery Feit, Gabriella Cohen, Ariel Feiglin, Weihan Liu, Francisco Hermida-Prado, Nikolas Kesten, Wen Ma, Carmine De Angelis, Antonio Morlando, Madison O'Donnell, Sergey Naumenko, Shixia Huang, Quang-De Nguyen, Ying Huang, Luca Malorni, Johann S Bergholz Villafane, Jean J Zhao, Ernest Fraenkel, Elgene Lim, Rachel Schiff, Geoffrey I Shapiro, Rinath M Jeselsohn
Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor-positive Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Marina Bacci, Nicla Lorito, Alfredo Smiriglia, Angela Subbiani, Francesca Bonechi, Giuseppina Comito, Ludivine Morisset, Rania El-Botty, Matteo Benelli, Joanna I López-Velazco, María M Caffarel, Ander Urruticoechea, George Sflomos, Luca Malorni, Michela Corsini, Luigi Ippolito, Elisa Giannoni, Icro Meattini, Vittoria Matafora, Kristina M Havas, Angela Bachi, Paola Chiarugi, Elisabetta Marangoni, Andrea Morandi
Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER + breast cancer. Science translational medicine 16 (736) (2024)
Ilenia Migliaccio, Dario Romagnoli, Francesca Galardi, Francesca De Luca, Chiara Biagioni, Curigliano Giuseppe, Carmen Criscitiello, Alessandro Marco Minisini, Erica Moretti, Emanuela Risi, Cristina Guarducci, Agostina Nardone, Laura Biganzoli, Matteo Benelli, Luca Malorni
Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial. JCO precision oncology 8 (2024)
Marina Bacci, Nicla Lorito, Alfredo Smiriglia, Angela Subbiani, Francesca Bonechi, Giuseppina Comito, Ludivine Morisset, Rania El-Botty, Matteo Benelli, Joanna I López-Velazco, María M Caffarel, Ander Urruticoechea, George Sflomos, Luca Malorni, Michela Corsini, Luigi Ippolito, Elisa Giannoni, Icro Meattini, Vittoria Matafora, Kristina M Havas, Angela Bachi, Paola Chiarugi, Elisabetta Marangoni, Andrea Morandi
Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER + breast cancer. Science translational medicine 16 (736) (2024)
Cristina Guarducci, Agostina Nardone, Douglas Russo, Zsuzsanna Nagy, Capucine Heraud, Albert Grinshpun, Qi Zhang, Allegra Freelander, Matthew Joseph Leventhal, Avery Feit, Gabriella Cohen, Ariel Feiglin, Weihan Liu, Francisco Hermida-Prado, Nikolas Kesten, Wen Ma, Carmine De Angelis, Antonio Morlando, Madison O'Donnell, Sergey Naumenko, Shixia Huang, Quang-De Nguyen, Ying Huang, Luca Malorni, Johann S Bergholz Villafane, Jean J Zhao, Ernest Fraenkel, Elgene Lim, Rachel Schiff, Geoffrey I Shapiro, Rinath M Jeselsohn
Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor-positive Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Ilenia Migliaccio, Marta Paoli, Emanuela Risi, Chiara Biagioni, Laura Biganzoli, Matteo Benelli, Luca Malorni
PIK3CA co-occurring mutations and copy-number gain in hormone receptor positive and HER2 negative breast cancer. NPJ breast cancer 8 (1) (2022)
Ilenia Migliaccio, Angela Leo, Francesca Galardi, Cristina Guarducci, Giulio Maria Fusco, Matteo Benelli, Angelo Di Leo, Laura Biganzoli, Luca Malorni
Circulating Biomarkers of CDK4/6 Inhibitors Response in Hormone Receptor Positive and HER2 Negative Breast Cancer. Cancers 13 (11) (2021)
Carmine De Angelis, Xiaoyong Fu, Maria Letizia Cataldo, Agostina Nardone, Resel Pereira, Jamunarani Veeraraghavan, Sarmistha Nanda, Lanfang Qin, Vidyalakshmi Sethunath, Nicholas Wang, Susan G Hilsenbeck, Matteo Benelli, Ilenia Migliaccio, Cristina Guarducci, Luca Malorni, Lacey M Litchfield, Jiangang Liu, Joshua Donaldson, Pier Selenica, David N Brown, Britta Weigelt, Jorge S Reis-Filho, Ben H Park, Sara A Hurvitz, Dennis J Slamon, Mothaffar F Rimawi, Valerie M Jansen, Rinath M Jeselsohn, C Kent Osborne, Rachel Schiff
Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (17) (2021)
Francesca Galardi, Francesca De Luca, Chiara Biagioni, Ilenia Migliaccio, Giuseppe Curigliano, Alessandro M Minisini, Martina Bonechi, Erica Moretti, Emanuela Risi, Amelia McCartney, Matteo Benelli, Dario Romagnoli, Silvia Cappadona, Stefano Gabellini, Cristina Guarducci, Valerio Conti, Laura Biganzoli, Angelo Di Leo, Luca Malorni
Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial. Breast cancer research : BCR 23 (1) (2021)
Matteo Benelli, Gian Marco Franceschini, Alberto Magi, Dario Romagnoli, Chiara Biagioni, Ilenia Migliaccio, Luca Malorni, Francesca Demichelis
Charting differentially methylated regions in cancer with Rocker-meth. Communications biology 4 (1) (2021)
Alessia Vignoli, Emanuela Risi, Amelia McCartney, Ilenia Migliaccio, Erica Moretti, Luca Malorni, Claudio Luchinat, Laura Biganzoli, Leonardo Tenori
Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer. International journal of molecular sciences 22 (9) (2021)
Samantha Di Donato, Alessia Vignoli, Chiara Biagioni, Luca Malorni, Elena Mori, Leonardo Tenori, Vanessa Calamai, Annamaria Parnofiello, Giulia Di Pierro, Ilenia Migliaccio, Stefano Cantafio, Maddalena Baraghini, Giuseppe Mottino, Dimitri Becheri, Francesca Del Monte, Elisangela Miceli, Amelia McCartney, Andrea Gombos, Claudio Luchinat, Laura Biganzoli
A Serum Metabolomics Classifier Derived from Elderly Patients with Metastatic Colorectal Cancer Predicts Relapse in the Adjuvant Setting. Cancers 13 (11) (2021)
Mariana Brandão, Rafael Caparica, Luca Malorni, Aleix Prat, Lisa Anne Carey, Martine Piccart
What Is the Real Impact of Estrogen Receptor Status on the Prognosis and Treatment of HER2-Positive Early Breast Cancer? Clinical cancer research : an official journal of the American Association for Cancer Research 26 (12) (2020)
Francesca Galardi, Francesca De Luca, Dario Romagnoli, Chiara Biagioni, Erica Moretti, Laura Biganzoli, Angelo Di Leo, Ilenia Migliaccio, Luca Malorni, Matteo Benelli
Cell-Free DNA-Methylation-Based Methods and Applications in Oncology. Biomolecules 10 (12) (2020)
Amelia McCartney, Martina Bonechi, Francesca De Luca, Chiara Biagioni, Curigliano Giuseppe, Erica Moretti, Alessandro Marco Minisini, Mattias Bergqvist, Matteo Benelli, Ilenia Migliaccio, Francesca Galardi, Emanuela Risi, Irene De Santo, Dario Romagnoli, Laura Biganzoli, Angelo Di Leo, Luca Malorni
Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (9) (2020)
Nicla Lorito, Marina Bacci, Alfredo Smiriglia, Michele Mannelli, Matteo Parri, Giuseppina Comito, Luigi Ippolito, Elisa Giannoni, Martina Bonechi, Matteo Benelli, Ilenia Migliaccio, Luca Malorni, Paola Chiarugi, Andrea Morandi
Glucose Metabolic Reprogramming of ER Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib. Cells 9 (3) (2020)